REVS

Columbia Research Enhanced Value ETF

31.5 4 USD

+0.29%

Сектор: Финансы

Базовая: USD

Валюта прибыли: USD

Дневной диапазон

Годовой диапазон

Дневное изменение

+0.29%

Месячное изменение

+1.84%

6-месячное изменение

+9.93%

Годовое изменение

+23.49%

Предыдущее закрытие

31.4 5

Open

31.5 4

Low

31.5 4

High

31.5 4

Volume

Открыть полный график

Обзор Все активы Тепловая карта

Ключевые активы Market Value Shares Weight %

NBIX Neurocrine Biosciences Inc 8 435.72000 62.00000 0.00429%

INSM Insmed Inc 8 314.11000 53.00000 0.00422%

DV DoubleVerify Holdings Inc 6 156.58000 569.00000 0.00313%

CONTRA WALGREENS BOOTS 5 814.50000 11.62900 K 0.00295%

IONS Ionis Pharmaceuticals Inc 4 133.50000 50.00000 0.00210%

SRPT Sarepta Therapeutics Inc 2 745.90000 135.00000 0.00140%

CAI Caris Life Sciences Inc 1 111.68000 48.00000 0.00056%

CONTRA MIRATI THERAPEU 25.50000 51.00000 0.00001%

REVS

Новости

Adding AI Resilience To Equity Portfolios

Why An Income-Centric Approach Matters For Investing In Retirement

Time To Consider Value?

Market Pullback: Healthy Reset, Not Bursting Stock Bubble

Equity Market Outlook Q4 2025 - Yes, There’s Still Room To Run

Dividend Investing: Thinking Beyond The Vanilla Approach

Value Investing In Volatile Times: Strategies For A Shifting Landscape

Q3 2025 Equity Market Outlook

Weekly Market Pulse: The Uncertainty Of Uncertainty (null:SPX)

A Stock Picker's Guide: Global Equity Market Opportunities Across A Shifting Landscape

Is Value Investing Making A Comeback?

Is It More Than Just Trade Tensions Weighing On The Markets?